Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**1-benzylimidazole** is a synthetic small molecule belonging to the class of N-substituted imidazoles. It is primarily used in research and as a chemical tool rather than as an approved pharmaceutical drug. The compound exhibits strong cardiotonic activity and acts as both an inducer of various cytochrome P450 (CYP) isozymes and an inhibitor of thromboxane A2 synthase. As a CYP inhibitor, it can modulate the metabolism of other compounds by affecting their biotransformation pathways. Its applications include use in biochemical studies involving enzyme inhibition and induction[2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-benzylimidazole.